Menopause, micronutrients, and hormone therapy

American Journal of Clinical Nutrition

Volumn 81, Issue 5, 2005, Pages

  Wylie Rosett, Judith ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Cancer; Estrogen; Heart disease; Herbal supplements; Menopausal symptoms; Micronutrients; Phytoestrogen; Progestin; Supplements

Indexed keywords

ALPHA TOCOPHEROL; CONJUGATED ESTROGEN; ESTRADIOL; ESTROGEN; FOLLITROPIN; GESTAGEN; HERBACEOUS AGENT; ISOFLAVONE DERIVATIVE; PHYTOESTROGEN; PLACEBO; PRASTERONE; TAMOXIFEN; TESTOSTERONE; THYROTROPIN; TRACE ELEMENT; VALPROIC ACID;

ANGELICA SINENSIS; CIMICIFUGA RACEMOSA; CLINICAL TRIAL; CONFERENCE PAPER; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DRUG RECEPTOR BINDING; ETHNOLOGY; GASTROINTESTINAL DISEASE; HORMONE SUBSTITUTION; HUMAN; LIVER FAILURE; MEDICAL RESEARCH; MENOPAUSAL SYNDROME; OBESITY; QUESTIONNAIRE; RASH; SIDE EFFECT; SOYBEAN; SYMPTOMATOLOGY; VAGINAL DRYNESS; ADULT; DRUG EFFECT; ESTROGEN THERAPY; FEMALE; MENOPAUSE; MIDDLE AGED; MULTICENTER STUDY; PHYSIOLOGY; PSYCHOLOGICAL ASPECT; REVIEW; WOMEN'S HEALTH;

ANGELICA SINENSIS; CIMICIFUGA RACEMOSA; GLYCINE MAX;

ADULT; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; MENOPAUSE; MICRONUTRIENTS; MIDDLE AGED; MULTICENTER STUDIES; PHYTOESTROGENS; WOMEN'S HEALTH;

EID: 20544468489     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/81.5.1223     Document Type: Conference Paper

References (49)

1. Women's Health Initiative Study Updates: WHI Hormone Program Update 2004. Internet: http://www.whi.org/updates/update_hrt2004.php (accessed July 24, 2004)
2. North American Menopause Society. Treatment of menopause-associated vasomotor symptoms: position statement of The North American Menopause Society. Menopause 2004;11:11-33.
3. Keenan NL, Mark S, Fugh-Berman A, Browne D, Laczmarczyk J, Hunter C. Severity of menopausal symptoms and use of both conventional and complementary alternatives Menopause 2003;10:507-15.
4. Overlie I, Moen MH, Holte A, Finset A. Androgens and estrogens in relation to flushes during the menopause transition. Maturitas 2002;41: 69-77.
5. Rock E, Dmachele A. Nutrition approaches to late toxicities of adjuvant chemotherapy in breast cancer survivors. J Nutr 2003;133(suppl): 3785S-93S.
6. Li C, Samsioe G, Borgfeldt C, Lidfeldt J, Agardh CD, Nerbrand C. Menopause-related symptoms: what are the background factors? A prospective population -based cohort study of Swedish women (The Women's Health In Lund Area study). Am J Obstet Gynecol 2003; 189:1646-53.
7. Schneider HP. The quality of life in the post-menopausal woman. Best Pract Res Clin Obstet Gynaecol. 2002;16:395-409.
8. Schneider B, van Trotsenburg M, Hanke G, Bigenzahn W, Huber J. Voice impairment and menopause. Menopause. 2004;11:151-8.
9. Gold EB, Block G, Crawford S, et al. Lifestyle and demographic factors in relation to vasomotor symptoms: baseline results from the Study of Women's Health Across the Nation. Am J Epid 2004;159:1189-99.
10. Sommer B, Avis N, Meyer P, et al. Attitudes toward menopause and aging across ethnic/racial groups. Pyschosomat Med 1999;61:868-75.
11. Hersh AL, Stefanick ML, Stafford RS. National use of postmenopausal hormone therapy: annual trends and response to recent evidence. JAMA 2004;291:47-53.
12. Writing group for the Women's Health Initiative investigators. Risk and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002;288:321-33.
13. The Women's Health Initiative Steering Committee. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative Randomized Controlled Trial. JAMA 2004; 291:1701-12.
14. Keating NL, Cleary PD, Rossi AS, Zaslavsky AM, Ayanian JZ. Use of hormone replacement therapy by postmenopausal women in the United States. Ann Intern Med 1999;6(130):545-53.
15. Hulley S, Grady D, Bush T, et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary health disease in post-menopausal women: Heart and Estrogen/progestin Replase Study (HERS) Research Group. JAMA 1998;280:605-13.
16. Schumaker SA, Legault C, Rapp SR, et al. for the WHIMS Investigators. Estrogen plus protestin and the incidence of dementia and mild cognitive impairment in postmenopausal women-the Women's Health Initiative Memory Study: a randomized controlled trial. JAMA 2003;289:2651-62.
17. Hays J, Ockene JK, Brunner RL, et al. for the Women's Health Initiative investigators. Effects of estrogen plus progestin on health-related quality of life. N Engl J Med 2003;348:1839-54.
18. Wasserthiel-Smoller S, Hendrix S, Limacher M, et al. for the Women's Health Initiative investigators. Effect of estrogen plus progestin on stroke in post menopausal women: the Women's Health Initiative. JAMA 2003;289:2673-84.
19. Chlebowski RT, Hendrix SL, Langer RD et al. Influence of estrogen plus progestin on breast cancer and mammography in health postmenopausal women: the Women's Health Initiative randomized trial. JAMA 2003; 289:3243-53.
20. Manson JE, Hsia J, Johnson KC, et al. for the Women's Health Initiative investigators. Estrogen plus progestin and the risk of coronary health disease. N Engl J Med 2003;349:523-34.
21. Shanafelt TD, Barton DL, Adjei AA, Loprinzi CL. Pathophysiology and treatment of hot flashes. Mayo Clin Proc 2002;77:1207-18.
22. Huntley AL, Ernst E. A systematic review of herbal medicine products for the treatment of menopausal symptoms. Menopause 2003; 10:465-76.
23. Dailey RK, Neale AV, Northrup J, West P, Schwartz KL. Herbal product use and menopausal symptom relief in primary care patients: MetroNet study. J Women's Health 2003;12:633-41.
24. Bair YA, Gold EB, Azari RA, et al. Ethnic differences in use of complementary and alternative medicine at midlife: Longitudinal results from SWAN participants. Am J Pub Health 2002;92:1832-40.
25. Lu LJW, Tice J, Bellino FL. Phytoestrogens and health aging: gaps in knowledge: a workshop report. Menopause 2001;8:157-70.
26. Philp HA. Hot flashes: a review of the literature on alternative and complementary treatment approaches. Alter Med Rev 2003;8:284-302.
27. Kronenberg F, Fugh-Berman A. Complementary and alternative medicine for menopausal symptoms: a review of randomized controlled, trials. Ann Intern Med 2002;137:805-13.
28. Moyad MA. Complementary/alternative medicine for reducing hot flashes in prostate cancer patient: revaluating the existing indirect data from studies of breast cancer and post menopausal women (Commentary). Urology 2002;59:(suppl 4S):20-2.
29. Powles T. Isoflavones and women's health. Breast Cancer Res 2004;6: 140-143.
30. Flint MP. Complementary and alternative medicine and menopause (editorial). Menopause 2003;10:492-3.
31. Prestwood KM. The search for alternative therapies for menopausal women: estrogenic effects of herbs (editorial). J Clin Endocrin Metab 2003;88:4075-6.
32. Cornwell T, Cohick W, Raskin I. Dietary photoestrogen and health. Phytochem 2004;65:995-1016.
33. Wuttke W, Jary H, Westphalen S, Christoffel V, Seidlova-Wuttke D. Phytoestrogens for hormone replacement therapy? J Steroid Biochem Mol Biol 2003;83:133-47.
34. Barton DL, Loprinzi CL, Quella SK, et al. Prospective evaluation of vitamin E for hot flashes in brease cancer survivors. J Clin Oncol 1998; 16:495-500.
35. Blumenthal M. The use of black cohosh to treat symptoms of menopause. Sex Reproduc Menopause 2004;2:27-34.
36. Anonymous Black cohosh Encyclopedia of Herbs. Internet: http://www.allnatural.net/herbpages/black-cohaost.shtml (accessed July 24, 2004).
37. Office of Dietary Supplements National Center for Complementary and Alternative Medicine National Institutes of Health. Questions and answers about black cohosh and the symptoms of menopause. Internet http://ods.od-.nih.gov/ factscheets/BlackCohosh.asp (accessed July 22, 2004).
38. Whiting PW, Clouston A, Kerlin P. Black cohosh and herbal remedies associated with acute hepatitis. Med J Australia 2002;177:440-3.
39. Kennelly EJ, Baggett S, Nuntanakorn P, et al. Analysis of thirteen populations of black cohosh for formononetin. Phytomedicine 2002;9:461-7.
40. Jacobson JS, Troxel AB, Evans J, et al. Randomized tirai of black cohost for the treatment of hot flashes among women with a history of breast cancer. J Clin Oncol 2001;19:2739-45.
41. Brooks JD, Ward WE, Lewis JE, et al. Supplementation with flaxseed alters estrogen metabolism in postmenopausal women to a greater extent than does supplementation with an equal amount of soy. Am J Clin Nutr 2004;79:318-25.
42. Van Patten CL, Olivotto IA, Chanbers GK, et al. Effect of soy phytoestrogens on hot flashes in post menopausal women with breast cancer: a randomized, controlled, trial. J Clin Oncol 2002;20:1449-55.
43. Tice JA, Ettinger B, Endsud K, Wallace R, Balckwell T, Cummings SR. Phytoestrogen supplements for the treatment of hot flashes: The Isoflavone Clover Extract (ICE) study: a randomized controlled trial. JAMA 2003;290:207-14.
44. Ju YH, Doerge DR, Allred KF, Allred CD, Helferich WG. Dietary genistein negates the inhibitory effect of tamoxifen on growth of estrogen-dependent human breast cancer (MCF-7) cells implanted in athymic mice. Cancer Res 2002;62:2474-7.
45. Anonymous. Dong quai Encyclopedia of Herbs. Internet: http://www.allnatural.net/herbpages/dibg-quai.shtml (accessed July 24, 2004).
46. Anonymous. Ginseng Encyclopedia of Herbs. Internet: http://www.all- natural.net/herbpages/gingeng.shtml (accessed July 24, 2004).
47. Salkovskis PM, Wroe AL, Rees MC. Shared decision-making, health choices and the menopause. J Br Menopause Soc 2004; 10(suppl) 1:13-7.
48. Amato P, Marcus DM. Review of alternative therapies for treatment of menopausal symptoms. Climacteric 2003;6:278-84.
49. Jenkins DJ, Kendall CW, Marchie A, et al. Effects of a dietary portfolio of cholesterol-lowering foods vs lovastatin on serum lipids and C-reactive protein. JAMA 2003;290(4):502-10.